Gareth Morgan is a Senior Vice President and is Global Head of Portfolio Management and AMR Policy for Shionogi.  In addition to leading the Portfolio Management team, Gareth is responsible for providing strategic and policy direction related to infectious diseases and frequently represents Shionogi on related government affairs and policy assignments. Gareth has 30 years of experience in the pharmaceutical industry, including clinical development and project/portfolio management positions with BMS, Bayer, Genentech (now Roche) and Hoechst-Roussel (now Sanofi).  He has led or provided functional and strategic oversight to development programs across multiple geographies and therapeutic areas.